
Xonejet S 250mg/125mg Injection
Marketer
Biofield Pharma
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Xonejet S 250mg/125mg Injection
Combiflox-S 250mg/125mg Injection, a dual-action antibiotic, effectively combats diverse bacterial infections. Its mechanism inhibits microbial growth, halting infection progression. Administration should strictly follow a healthcare professional's guidance; consistent adherence to the prescribed schedule is crucial, completing the full course even with symptom improvement. Premature cessation may compromise treatment efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration are recommended for optimal recovery. Your doctor may order tests to monitor the medication's impact.
Primary Ingredients of Xonejet S 250mg/125mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Xonejet S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Xonejet S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Xonejet S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Xonejet S 250mg/125mg Injection:
This medication will be administered by your physician or their designated nursing staff; self-medication is strictly prohibited.
How Xonejet S 250mg/125mg Injection works:
Xonejet S Injection (250mg Ceftriaxone/125mg Sulbactam) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counters bacterial resistance, thereby optimizing Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Xonejet S 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Xonejet S (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, data from human trials are scarce.
Breast feedingCAUTION
Administering Xonejet S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Xonejet S 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Xonejet S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Patients with severe hepatic impairment should receive Xonejet S 250mg/125mg Injection cautiously, with potential dose modification. For patients with mild to moderate liver disease, dose alteration of Xonejet S 250mg/125mg Injection is unnecessary; however, medical advice is always recommended.
What if you forget to take Xonejet S 250mg/125mg Injection :
Should you forget a scheduled dose of Xonejet S 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Xonejet S 250mg/125mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Agents against infection |
